Overview
Cirrhotic cardiomyopathy is a functional cardiac disorder characterized by impaired myocardial contractility, diastolic dysfunction, and autonomic imbalance, often observed in patients with advanced liver disease, independent of traditional cardiomyopathic etiologies 1.Diagnosis
Echocardiography to assess left ventricular ejection fraction and diastolic function 1.
Electrocardiographic analysis for signs of arrhythmias or conduction abnormalities 1.
Elevated systemic bile acid levels may correlate with cardiomyopathy severity 1.Management
Liver transplantation can reverse some features of cirrhotic cardiomyopathy, suggesting a potential therapeutic approach 1.
Reduction of systemic bile acid levels through dietary modifications or specific interventions may be beneficial 1.Special Populations
No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Consider liver transplantation as a therapeutic option to reverse cirrhotic cardiomyopathy features (Evidence: Moderate 1).
Monitor and manage systemic bile acid levels as a potential adjunct in the management of cirrhotic cardiomyopathy (Evidence: Weak 1).
Regular echocardiographic evaluations are essential for early detection and monitoring of cardiac dysfunction in cirrhotic patients (Evidence: Expert opinion 1).References
1 Desai MS, Eblimit Z, Thevananther S, Kosters A, Moore DD, Penny DJ et al.. Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis. Liver international : official journal of the International Association for the Study of the Liver 2015. link